Results 61 to 70 of about 2,702,342 (191)

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. [PDF]

open access: yes, 2017
BACKGROUND: Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS: We performed a multicenter, prospective, open-label study to determine whether 5 g of intravenous idarucizumab would be ...
Bernstein, Richard A.   +20 more
core   +1 more source

Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism [PDF]

open access: yes, 2014
Acute pulmonary embolism (PE) can diminish patient quality of life (QoL). The objective was to test whether treatment with tenecteplase has an independent effect on a measurement that reflects QoL in patients with submassive PE.
Courtney, D. Mark   +9 more
core   +1 more source

An atypical case of pulmonary embolism from a jugular vein

open access: yesEcho Research and Practice, 2018
Neck venous malformations and their potentially life-threatening complications are rarely reported in the available literature. Cases of aneurysmal or hypo-plastic jugular vein thrombosis associated with systemic embolization have not been frequently ...
A E Velcea   +4 more
doaj   +1 more source

A Rare Case of Pulmonary Embolism, Deep Vein Thrombosis, Bilateral Avascular Necrosis of the Femoral Head, and Miscarriage following COVID-19 in a Patient with Multiple Genetic Coagulation Factor Deficiency—A Case Report

open access: yesLife, 2023
The coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The most common symptoms of COVID-19 are respiratory symptoms, but some patients develop severe thrombotic complications.
Nevena Georgieva Ivanova
doaj   +1 more source

Efficacy of pro‐haemostatic agents in the management of factor Xa inhibitor‐associated intracranial haemorrhages

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background An increasing number of patients in Australia are taking direct oral anticoagulants for a variety of indications since their introduction in the treatment landscape. There has always been some concern about the optimal management approach in the setting of major and/or life‐threatening bleeding.
Sara Shu‐Ling Ng   +4 more
wiley   +1 more source

Epidemiological updates of venous thromboembolism in a Chinese population [PDF]

open access: yes, 2018
published_or_final_versio
Chan, YC, Cheng, SWK, Law, Y
core   +1 more source

Deep Vein Thrombosis (DVT) Pasca Cedera Otak Traumatik Berat

open access: yesJurnal Neuroanestesi Indonesia, 2019
Cedera otak traumatik(COT) adalah penyebab utama kematian dan disabilitas. Deep vein thrombosis (DVT) adalah salah satu risiko tinggi dari COT. Faktor risiko DVT lain yang umum ditemukan pada pasien COTadalah paralisis, imobilisasi, dan cedera ortopedi ...
Nency Martaria   +2 more
doaj   +1 more source

2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri‐operative and bleeding management

open access: yesInternal Medicine Journal, EarlyView.
Abstract Direct oral anticoagulants (DOACs) are widely prescribed to prevent and treat venous and arterial thromboembolism, supported by published evidence, and are preferred over warfarin in many guidelines. Although the risk of major bleeding, in particular intracranial haemorrhage (ICH), is decreased with DOACs, gastrointestinal bleeding is ...
Huyen A. Tran   +7 more
wiley   +1 more source

Early surgery versus initial conservative treatment in patients with traumatic intracerebral haemorrhage [STITCH(Trauma)] : the first randomized trial [PDF]

open access: yes, 2015
Acknowledgements This project was funded by the NIHR Health Technology Assessment programme (project number 07/37/16). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS ...
A. David Mendelow   +10 more
core   +1 more source

Nomogram for Deep Vein Thrombosis Prediction Post‐Endovascular Thrombectomy in Acute Ischemic Stroke: A Retrospective Multicenter Observational Study

open access: yesJournal of Clinical Nursing, EarlyView.
ABSTRACT Background Deep vein thrombosis (DVT) is a frequent complication following endovascular thrombectomy (EVT) in patients with acute ischaemic stroke (AIS), potentially leading to fatal pulmonary embolism (PE). Identifying patients early at high risk for DVT is clinically important.
Li Han   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy